در حال جستجو در محتوی

ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 4 مورد
Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults
Eosinophilic fasciitis
Eosinophilic fasciitis
Gastrointestinal manifestations of systemic sclerosis (scleroderma)
Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)
Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma)
Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, risk factors, and screening
Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma)
Cardiac manifestations of systemic sclerosis (scleroderma)
Neuromuscular manifestations of systemic sclerosis (scleroderma)
Mixed connective tissue disease
Undifferentiated systemic rheumatic (connective tissue) disease and overlap syndromes
Pathogenesis and pathophysiology of Raynaud phenomenon
Pathogenesis of systemic sclerosis (scleroderma)
Risk factors for and possible causes of systemic sclerosis (scleroderma)
Systemic sclerosis (scleroderma) and pregnancy
Clinical manifestations and diagnosis of Raynaud phenomenon
Pathogenesis and pathophysiology of Raynaud phenomenon
Treatment of Raynaud phenomenon: Initial management
Treatment of severe or refractory Raynaud phenomenon
Kidney disease in systemic sclerosis (scleroderma), including scleroderma renal crisis
Cyclophosphamide in rheumatic diseases: General principles of use and toxicity
Hand surgery in patients with systemic sclerosis (scleroderma)
Immunomodulatory and antifibrotic approaches to the treatment of systemic sclerosis (scleroderma)
Overview of the treatment and prognosis of systemic sclerosis (scleroderma) in adults
Preoperative evaluation and perioperative management of patients with rheumatic diseases
Pretreatment evaluation of adults with systemic sclerosis (scleroderma)
Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, risk factors, and screening
Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma)